Boston Scientific will add Devoro Medical’s Wolf platform to its range of thrombectomy devices by acquiring the share of Devoro that it does not already own.
Boston Scientific bought a 16% stake in Fremont, CA-based Devoro in 2019. On 21 September, it announced that it has...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?